Literature DB >> 33585451

Identification of the Myogenetic Oligodeoxynucleotides (myoDNs) That Promote Differentiation of Skeletal Muscle Myoblasts by Targeting Nucleolin.

Sayaka Shinji1, Koji Umezawa2,3, Yuma Nihashi4, Shunichi Nakamura1, Takeshi Shimosato1,2,3,4, Tomohide Takaya1,2,3,4.   

Abstract

Herein we report that the 18-base telomeric oligodeoxynucleotides (ODNs) designed from the Lactobacillus rhamnosus GG genome promote differentiation of skeletal muscle myoblasts which are myogenic precursor cells. We termed these myogenetic ODNs (myoDNs). The activity of one of the myoDNs, iSN04, was independent of Toll-like receptors, but dependent on its conformational state. Molecular simulation and iSN04 mutants revealed stacking of the 13-15th guanines as a core structure for iSN04. The alkaloid berberine bound to the guanine stack and enhanced iSN04 activity, probably by stabilizing and optimizing iSN04 conformation. We further identified nucleolin as an iSN04-binding protein. Results showed that iSN04 antagonizes nucleolin, increases the levels of p53 protein translationally suppressed by nucleolin, and eventually induces myotube formation by modulating the expression of genes involved in myogenic differentiation and cell cycle arrest. This study shows that bacterial-derived myoDNs serve as aptamers and are potential nucleic acid drugs directly targeting myoblasts.
Copyright © 2021 Shinji, Umezawa, Nihashi, Nakamura, Shimosato and Takaya.

Entities:  

Keywords:  berberine (CID: 12457); myogenic differentiation; nucleolin (NCL); oligodeoxynucleotide (ODN); skeletal muscle myoblast

Year:  2021        PMID: 33585451      PMCID: PMC7874222          DOI: 10.3389/fcell.2020.616706

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  80 in total

1.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

Review 2.  G-quadruplexes: targets in anticancer drug design.

Authors:  Tian-miao Ou; Yu-jing Lu; Jia-heng Tan; Zhi-shu Huang; Kwok-yin Wong; Lian-quan Gu
Journal:  ChemMedChem       Date:  2008-05       Impact factor: 3.466

3.  Wasting as independent risk factor for mortality in chronic heart failure.

Authors:  S D Anker; P Ponikowski; S Varney; T P Chua; A L Clark; K M Webb-Peploe; D Harrington; W J Kox; P A Poole-Wilson; A J Coats
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

4.  Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin.

Authors:  Masatoshi Takagi; Michael J Absalon; Kevin G McLure; Michael B Kastan
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

Review 5.  Berberine and barberry (Berberis vulgaris): A clinical review.

Authors:  Mohsen Imenshahidi; Hossein Hosseinzadeh
Journal:  Phytother Res       Date:  2019-01-13       Impact factor: 5.878

6.  Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.

Authors:  C Sackesen; W van de Veen; M Akdis; O Soyer; J Zumkehr; B Ruckert; B Stanic; O Kalaycı; S S Alkan; I Gursel; C A Akdis
Journal:  Allergy       Date:  2013-03-09       Impact factor: 13.146

7.  Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 down-regulation.

Authors:  Jae-Ho Chang; Eun-Ju Chang; Hong-Hee Kim; Soo-Ki Kim
Journal:  Biochem Biophys Res Commun       Date:  2009-08-19       Impact factor: 3.575

8.  Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin.

Authors:  Simona Iezzi; Monica Di Padova; Carlo Serra; Giuseppina Caretti; Cristiano Simone; Eric Maklan; Giulia Minetti; Po Zhao; Eric P Hoffman; Pier Lorenzo Puri; Vittorio Sartorelli
Journal:  Dev Cell       Date:  2004-05       Impact factor: 12.270

9.  Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells.

Authors:  Lacey M Litchfield; Krista A Riggs; Alyson M Hockenberry; Laura D Oliver; Katelyn G Barnhart; Jian Cai; William M Pierce; Margarita M Ivanova; Paula J Bates; Savitri N Appana; Susmita Datta; Piotr Kulesza; Jean McBryan; Leonie S Young; Carolyn M Klinge
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

View more
  2 in total

1.  Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner.

Authors:  Yuma Nihashi; Mana Miyoshi; Koji Umezawa; Takeshi Shimosato; Tomohide Takaya
Journal:  Nanomaterials (Basel)       Date:  2022-05-14       Impact factor: 5.719

2.  Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus.

Authors:  Shunichi Nakamura; Shinichi Yonekura; Takeshi Shimosato; Tomohide Takaya
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.